Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. - Wikidata - wikimedia - TriplyDB

Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

http://www.wikidata.org/entity/Q36503183

about

Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction Epigenetic mechanisms underlying cardiac degeneration and regeneration Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction Methodological challenges in utilizing miRNAs as circulating biomarkers miRNome in myocardial infarction: Future directions and perspective Novel methodologies for biomarker discovery in atherosclerosis Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction Membrane-associated matrix proteolysis and heart failure.MicroRNAs expression profiles in cardiovascular diseases.Biomarkers of coronary artery disease: the promise of the transcriptome.A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction.MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort.Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction.The biology of circulating microRNAs in cardiovascular disease.Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling.Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs MicroRNA Regulation of Atherosclerosis.Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.MiR-29a modulates the angiogenic properties of human endothelial cells.MicroRNAs in metabolic disease.Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis.Integrating the myocardial matrix into heart failure recognition and management.Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.Gene Expression Signatures and the Spectrum of Coronary Artery Disease.MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.MicroRNAs in the thyroid.MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.Ischemia/Reperfusion.Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.Role of microRNAs in obesity and obesity-related diseases.Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients.Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.Serum miRNA-499 and miRNA-210: A potential role in early diagnosis of acute coronary syndrome.Cardioprotective Effect of MicroRNA-21 in Murine Myocardial Infarction.Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression.Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction.

P2860

Q26771125-EE18D2DE-5A7D-4C8B-BF56-F49B29B9F8E8 Q26853220-F92B83DA-8CAF-4615-8127-3665D355C861 Q26862733-DF08C442-BEBC-42AB-8635-0953D69FF4A3 Q27027950-303CBEE1-3A9F-489A-B6D6-2FFA61FF06BD Q27028108-27035E2B-83FF-426F-B911-261CAB661792 Q28088373-CDE231ED-73D1-4C0C-A320-8CD9AC8C3F06 Q30387502-C4946AD2-F675-47A3-B373-D577206B1366 Q33580495-DD2717EE-0565-4633-AD86-2425C4BF1902 Q33632033-9B91C6E5-6AA7-448A-94B0-FFF4E6F2546E Q33821302-F0C404BC-FDCF-4EE9-BE29-87CFE1D5230E Q34507146-9E959EA5-5055-4302-A9F4-6F07DB9BD19F Q34962538-27B35994-DF48-4BC4-8A21-EBD7BEE0D407 Q35137663-DD038CB1-A27D-4EA3-98FA-19078D276A54 Q35694667-74ABDAF2-14D4-4E94-A67B-45E5C887B411 Q35888026-B693DBFB-309E-49FF-925D-02EB277EDE0C Q35983836-1C14D841-4C01-4501-B4A2-1FD79DF2EFA9 Q36389315-08374385-9D56-418E-BADE-F398329971D2 Q36602813-071AF8E6-F756-4A31-8509-EC5C30D0F2FB Q36819566-1D5BD473-D79D-42A8-AA4C-33DA520CE8F5 Q36822851-462972B4-F6C3-4CD3-932F-4FAC45C1AF45 Q37088373-C3AD7404-E1CF-4709-921F-9D74CDEABD0D Q37310442-8902B9DF-2799-41D2-A82C-A11F61D0B922 Q37406111-F2098C8B-9376-40D1-AF27-A3098A79C864 Q38125100-D7C5FA95-E310-4597-A909-37F773CD1C98 Q38166071-F8F9E0E7-2797-4395-AE6A-1FF5663038A1 Q38404768-6265D6F0-5701-4FC8-9B6C-9FCA9EB4A774 Q38531858-BE5C1D40-01DB-4E28-895B-411152B4477A Q38888119-B380A0F2-B46D-4153-9065-E825C389AB1A Q39030847-1AE93CBF-915C-4106-9CCE-7B4991A6FA4F Q39038069-2F70B992-996C-476B-9C75-C38031105CC6 Q39109413-0C4B6E1F-96FE-4505-A139-FE0D62082DDD Q41165846-1000B39F-F2FA-4034-862A-861FA6F0CB8A Q41873853-D09259AC-0D53-481C-86FB-3F87A9D79FCD Q44550288-B10CF39B-2598-4E91-B05C-AE1E90DB9462 Q45083013-FF942DE9-0DC0-4408-8BA1-54994DC2B7BE Q46640892-6C4F16A2-1609-4147-8440-FB279591A218 Q52956195-FF38CE8C-31EB-4FE5-82A1-AC94493476A4 Q54223894-032023C7-2FF1-4E3D-BEB6-FF0EA05C7661 Q55078854-C7C43D13-EC4B-45C8-8019-E7A5C2AF093F Q55381244-724027C3-BA89-413E-8A18-84D2A6C1BA4E

P2860

Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

http://www.wikidata.org/entity/Q36503183

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Relationship between the tempo ...... s after myocardial infarction.

@ast

Relationship between the tempo ...... s after myocardial infarction.

@en

type

label

Relationship between the tempo ...... s after myocardial infarction.

@ast

Relationship between the tempo ...... s after myocardial infarction.

@en

prefLabel

Relationship between the tempo ...... s after myocardial infarction.

@ast

Relationship between the tempo ...... s after myocardial infarction.

@en

P1433

Q36503183-6C7A7EB4-686A-4F3C-B191-C6C4337DA065

P1476

Q36503183-E7A7222A-4579-49BA-A6F9-5340720ACF9C

P2093

Q36503183-129485FB-C01A-41C4-B7F7-132A1B92DF56

Q36503183-34079F7F-A8C3-46CD-90D0-930475E6A483

Q36503183-6A164BEE-AE94-4185-A8A6-C89AC40EA17E

Q36503183-ABDAA32D-2DC4-4DBE-AEC4-D929E3566467

Q36503183-C9E87F6E-00E8-4421-A135-9809B4458FBA

Q36503183-EFEBB272-C722-4596-BBC4-EA55B2452747

P2860

Q36503183-165C407D-48AC-409F-BF82-86811199F0AB

Q36503183-21623358-CF30-4E04-82F9-645A44A088AD

Q36503183-2217200D-A984-4CEC-9E1E-83EE3CAEE276

Q36503183-275781A6-968E-481D-9D83-6E1842AE3D12

Q36503183-2D20D0AF-7063-42E7-9867-B0983EDA38C6

Q36503183-3458E150-105C-4B00-B1FA-084281A959F4

Q36503183-363E4E7A-709B-47AE-A35E-A601290DFF35

Q36503183-36BC0DC8-40F4-4A2F-84EA-DD7797F3E28D

Q36503183-37FD0452-AD01-440B-9E00-8E15FFD0D6F8

Q36503183-3B777B3E-2DDF-4E82-B218-91F4728B55EB

P304

Q36503183-C7D7141B-0356-4260-B456-93BE279B037D

P31

Q36503183-75E23C81-94CF-4598-8D70-1702C96CFF5B

P356

Q36503183-4DE70797-5BDB-4F26-B3BB-7724F991F85A

P433

Q36503183-8A98A83D-04E9-4A5C-921C-A2C0E66F01C8

P478

Q36503183-5D48138A-CCDE-45AC-BEB6-520ECACF42AE

P577

Q36503183-AB7DEA2F-2817-4886-9300-0ECBAFE32EAF

P5875

Q36503183-0CA5E3C2-98E9-4583-ACAA-676D11AE8F70

P698

Q36503183-2E3F5EDA-195D-47C0-8506-08B82D27A039

P921

Q36503183-6722E3A2-A0D1-4C02-9BB1-0852470FF654

Q36503183-D0635138-26B8-4C13-AFE8-DEA5AA06736A

P932

Q36503183-F5FBF006-91D0-4ECF-A913-902EAECAE70E

P356

CIRCGENETICS.111.959841

P1433

Circulation: Cardiovascular Genetics

P1476

Relationship between the tempo ...... s after myocardial infarction.

@en

P2093

Francis G Spinale

http://www.w3.org/2001/XMLSchema#string

Jazmine E Arroyo

http://www.w3.org/2001/XMLSchema#string

Michael R Zile

http://www.w3.org/2001/XMLSchema#string

Robert E Stroud

http://www.w3.org/2001/XMLSchema#string

Shannon M Mehurg

http://www.w3.org/2001/XMLSchema#string

Stacia M DeSantis

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction

Circulating microRNAs as stable blood-based markers for cancer detection.

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

P304

614-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCGENETICS.111.959841

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51678813

http://www.w3.org/2001/XMLSchema#string

P698

21956146

http://www.w3.org/2001/XMLSchema#string

P921

P932

3535326

http://www.w3.org/2001/XMLSchema#string